Colorimetric fluoride detection in dimethyl sulfoxide using a heteroleptic ruthenium(ii) complex with amino and amide groups: X-ray crystallographic and spectroscopic analyses.

A bis-heteroleptic ruthenium(ii) complex, [Ru(Hdpa)(Hpia)]X (1·X; X = Cl, OTf, or F; Hdpa = di-2-pyridylamine; Hpia = 2-pycolinamide; OTf = CFSO ), was synthesized and spectroscopically and crystallographically characterized. The crystal structures of 1·Cl·2.5HO and 1·F·2EtOH revealed essentially identical geometries for the 1 dication; however, the dihedral angle between the two pyridyl groups in the Hdpa ligands, which represented the degree of bending of the bent conformation, was affected by hydrogen-bonding interactions between the NH group and counterions.

Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.

Background/aims: Approximately 20-40% of patients with gastroesophageal reflux disease (GERD) are refractory to proton pump inhibitor (PPI) treatment. The acid-inhibitory effect of vonoprazan, a novel potassium-competitive acid blocker (P-CAB), is significantly greater when compared to the effect of PPIs. We investigated the efficacy of vonoprazan treatment for PPI-refractory GERD and factors associated with P-CAB non-response.

Associations among gastroesophageal reflux disease, psychological stress, and sleep disturbances in Japanese adults.

Background And Aim: Gastroesophageal reflux disease (GERD) and psychological stress are associated with sleep disturbances. The aim of the present study was to examine the prevalence of sleep disturbances, anxiety, and depression by GERD subtypes and to identify factors associated with sleep disturbances in general population.

Methods: A total of 2002 Japanese subjects, who underwent annual health checkups, were enrolled and asked to fill out a questionnaire, including the frequency scale for the symptoms of GERD (FSSG), Athens Insomnia Scale (AIS), Rome III questionnaire, and Hospital Anxiety and Depression Scale (HADS).